You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epitelial ovarian cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Shanghai Ovarian Cancer and Family Care Project

Recruiting
  • Ovarian Cancer
    • Shanghai, Shanghai, China
      Shanghai first maternity and infant hospital
    Oct 31, 2023

    Transforming Ovarian Cancer Diagnostic Pathways

    Not yet recruiting
    • Ovarian Cancer
      • Birmingham, United Kingdom
      • +2 more
      Nov 10, 2023

      Epithelial Ovarian Cancer: A Retrospective Study

      Recruiting
      • Epithelial Ovarian Cancer
      • Hematologic features
      • Shanghai, Shanghai, China
        Renji Hospital Affiliated to Shanghai Jiao Tong University Schoo
      Oct 16, 2023

      Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

      Not yet recruiting
      • Ovarian Cancer Recurrent
      • Fluzopril Combined With Apatinib
      • (no location specified)
      Oct 22, 2023

      Total Management of Ovarian Cancer

      Not yet recruiting
      • Tumor of Female Reproductive System
      • Ovarian Cancer
      • No intervention
      • (no location specified)
      Aug 30, 2023

      Early Screening of Epithelial Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • +2 more
      • Fragmentomics
      • (no location specified)
      Jun 26, 2023

      Platinum-resistant Ovarian Cancer

      Not yet recruiting
      • Ovarian Cancer
      • pegylated liposomal doxorubicin
      • (no location specified)
      Aug 2, 2023

      Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

      Not yet recruiting
      • Serous Ovarian Cancer
      • Advanced Ovarian Cancer
      • (no location specified)
      Sep 20, 2023

      Ovarian Cancer Trial in Helsinki (Biomolecular profiling)

      Recruiting
      • Ovarian Cancer
      • Biomolecular profiling
      • Helsinki, Finland
        Helsinki University and Helsinki University Hospital
      Nov 1, 2023

      Ovarian Cancer Trial in France (tests to determine HRD status)

      Not yet recruiting
      • Ovarian Cancer
      • tests to determine HRD status
      • Amiens, France
      • +3 more
      Nov 22, 2023

      Metabolic Biomarkers and Their Prognostic Relationship in

      Not yet recruiting
      • Ovarian Cancer
      • No intervention
      • (no location specified)
      Aug 24, 2023

      A Prospective, Randomized Controlled Study of Cyclophosphamide,

      Not yet recruiting
      • Epithelial Ovarian Cancer
      • Shijiazhuang, Hebei, China
        Hebei
      Aug 20, 2023

      Participation Patterns Among Recurrent Ovarian Cancer Patients

      Not yet recruiting
      • Recurrent Ovarian Cancer
        • San Francisco, California
          Power Life Sciences
        Sep 30, 2023

        Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

        Not yet recruiting
        • Ovarian Cancer
        • Olaparib tablet
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Nov 1, 2023

        Ovarian Cancer Trial (Aribulin;carboplatin;bevacizumab)

        Not yet recruiting
        • Ovarian Cancer
        • (no location specified)
        Jul 20, 2023

        Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Minsk (Gemcitabine, ELENAGEN)

        Active, not recruiting
        • Ovarian Cancer
        • Platinum-resistant Ovarian Cancer
        • Minsk, Belarus
          Minsk City Clinical Oncology Center
        Jul 27, 2023

        Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial (Artificial Intelligence)

        Not yet recruiting
        • Ovarian Cancer Stage III
        • Ovarian Cancer Stage IV
        • Artificial Intelligence
        • (no location specified)
        Aug 24, 2023

        Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)

        Not yet recruiting
        • Ovarian Cancer
        • +5 more
        • MIRRORS Protocol
        • Standard Open Cytoreductive Surgery
        • (no location specified)
        Jul 17, 2023

        Ovarian Cancer Trial in Roma (Blood sample)

        Recruiting
        • Ovarian Cancer
        • Blood sample
        • Roma, Italy
          Policlinico Universitario Agostino Gemelli
        Oct 10, 2023

        Safety of Niraparib in Korean Primary and Recurrent Epithelial

        Completed
        • Epithelial Ovarian Cancer
        • Seoul, Korea, Republic of
          Department of Obstetrics and Gynecology, University of Ulsan Col
        Oct 11, 2023

        Ovarian Cancer Trial in Goyang (Cisplatin)

        Not yet recruiting
        • Ovarian Cancer
        • Goyang, Gyeonggi, Korea, Republic of
          National Cancer Center
        Apr 24, 2023

        Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

        Not yet recruiting
        • Ovarian Cancer
        • +3 more
        • Beijing, Beijing, China
          Lingying Wu
        Aug 22, 2023

        ctDNA Predicts Recurrence of Advanced Ovarian Cancer After

        Recruiting
        • Ovarian Cancer Stage IV
        • Ovarian Cancer Stage III
          • Guangzhou, Guangdong, China
            Sun Yat-Sen Memorial Hospital
          Aug 30, 2023

          Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)

          Not yet recruiting
          • Recurrent Ovarian Cancer
          • Pittsburgh, Pennsylvania
            Magee-Womens Research Institute / UPMC Magee Womens Hospital
          Jul 3, 2023

          Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

          Not yet recruiting
          • Ovarian Cancer
          • +4 more
          • Guangzhou, Guangdong, China
            Sun Yat-sen University Cancer Cetntre
          Sep 25, 2023